1.
Clin Case Rep
; 11(8): e7741, 2023 Aug.
Artículo
en Inglés
| MEDLINE
| ID: mdl-37575459
RESUMEN
At 22 weeks post-transplantation for HBV-related cirrhosis, an adult woman developed neutropenia which was aggravated by COVID-19 (ANC 0.4 × 109/L). Covid resolution and all "conventional" modifications were ineffective. Success within 2 weeks was achieved by switching entecavir to tenofovir alafenamide. A step-by-step judicious approach to post-transplant neutropenia is vital.